It has good gastrointestinal fluid tolerance, intestinal adhesion ability and antibacterial ability. It can also effectively inhibit pathogenic bacteria such as Shigella flexneri and increase the relative abundance of beneficial bacteria in the intestines of mice

Animal experiments show that LC89 can alleviate diabetic symptoms by improving fasting blood sugar, lowering blood lipids and serum insulin, reducing inflammation, protecting the pancreas and liver, restoring intestinal flora disorders caused by diabetes, and improving body health

It can inhibit the growth and proliferation of various Helicobacter pylori subtypes, inhibit the adhesion of Helicobacter pylori to gastric epithelial cells, and significantly reduce the colonization and inflammatory response of different subtypes of Helicobacter pylori, creating a basis for the eradication of Helicobacter pylori conditions

Population trials have shown that it effectively reduces the levels of inflammatory factors in patients with Helicobacter pylori infection and significantly reduces the adhesion of Helicobacter pylori to gastric epithelial cells. At the same time, it has a strong inhibitory effect on pathogenic bacteria such as Streptococcus mutans, Streptococcus cousinis, Streptococcus sanguinis, Proteus, Helicobacter pylori, Bacteroides fragilis, Listeria monocytogenes and other pathogenic bacteria